SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Rapp Edward J – ‘4’ for 9/30/23 re: AbbVie Inc.

On:  Tuesday, 10/3/23, at 5:00pm ET   ·   For:  9/30/23   ·   As:  Director   ·   Accession #:  1415889-23-13896   ·   File #:  1-35565

Previous ‘4’:  ‘4’ on 7/13/23 for 7/12/23   ·   Next:  ‘4’ on 10/12/23 for 10/10/23   ·   Latest:  ‘4’ on 5/7/24 for 5/3/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/03/23  Rapp Edward J                     4          Director    2:8K   AbbVie Inc.                       SEC Connect

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      6K 
                Securities by an Insider --                                      
                form4-10032023_051004.xml/5.8                                    
 2: EX-24       Power of Attorney                                   HTML      6K

‘4’   —   Statement of Changes in Beneficial Ownership of Securities by an Insider — form4-10032023_051004.xml/5.8



        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider — form4-10032023_051004.xml/5.8
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0508 </schemaVersion>
<documentType> 4 </documentType>
<periodOfReport> 2023-09-30 </periodOfReport>
<issuer>
<issuerCik> 0001551152 </issuerCik>
<issuerName> AbbVie Inc. </issuerName>
<issuerTradingSymbol> ABBV </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001171780 </rptOwnerCik>
<rptOwnerName> RAPP EDWARD J </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> 1 N. WAUKEGAN ROAD </rptOwnerStreet1>
<rptOwnerStreet2></rptOwnerStreet2>
<rptOwnerCity> NORTH CHICAGO </rptOwnerCity>
<rptOwnerState> IL </rptOwnerState>
<rptOwnerZipCode> 60064 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> true </isDirector>
<isOfficer> false </isOfficer>
<isTenPercentOwner> false </isTenPercentOwner>
<isOther> false </isOther>
<officerTitle></officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One> 0 </aff10b5One>
<nonDerivativeTable></nonDerivativeTable>
<derivativeTable>
<derivativeTransaction>
<securityTitle>
<value> Stock Equivalent Units </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 149.06 </value>
</conversionOrExercisePrice>
<transactionDate>
<value> 2023-09-30 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> A </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 259 </value>
</transactionShares>
<transactionPricePerShare>
<value> 149.06 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> A </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<exerciseDate>
<footnoteId id="F1"/>
</exerciseDate>
<expirationDate>
<footnoteId id="F1"/>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 259 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 24750 </value>
<footnoteId id="F2"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value></value>
</natureOfOwnership>
</ownershipNature>
</derivativeTransaction>
</derivativeTable>
<footnotes>
<footnote id="F1"> Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. </footnote>
<footnote id="F2"> Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. </footnote>
</footnotes>
<ownerSignature>
<signatureName> T.O. Odutayo, attorney-in-fact for Edward J. Rapp </signatureName>
<signatureDate> 2023-10-03 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001415889-23-013896   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 11:31:03.2am ET